Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-100.82	-63.44	-31.59
Graham Fair Price	-28.16	1407.10	1958.60
PEG	261.12	0.12	-0.03
Price/Book	-35.06	1.27	1.96
Price/Cash Flow	-133.84	-52.51	-22.46
Prices/Earnings	-137.96	-7.44	-3.13
Price/Sales	-7.04	11.76	12.65
Price/FCF	-133.84	-52.51	-22.46
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	33.26	0.44	0.33
Operating Margin	59.03	-0.18	-0.43
ROA	71.87	-0.04	-0.13
ROE	-0.16	-0.04	72.71
ROIC	-0.07	-0.02	74.87
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	6.64	-0.49	1250.39
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.52	0.59	12.56
EPS QOQ	-0.95	0.62	-34.10
FCF QOQ	< 0.005	0.60	10894.21
Revenue QOQ	0.03	0.01	-51.98
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	181.70	222.31	22.35
Days Sales Outstanding (DSO)	56.53	50.67	-10.37
Inventory Turnover	0.50	0.40	-18.27
Debt/Capitalization	< 0.005	0.04	410.62
Quick Ratio	0.92	3.26	253.19
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1042.90	1434.29	37.53
Cash	57.55	569.39	889.39
Capex	2.08	-0.36	-82.82
Free Cash Flow	-91.00	-34.75	61.81
Revenue	161.58	155.23	-3.93
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.30	4.41	92.02
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.78	20.61	2525.96
Naive Interpretation	Member

06 - Financial Health · Bad

Rating